Premium
Increased prevalence of mutant null alleles that cause hereditary fructose intolerance in the American population
Author(s) -
Coffee Erin M.,
Yerkes Laura,
Ewen Elizabeth P.,
Zee Tiffany,
Tolan Dean R.
Publication year - 2010
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/s10545-009-9008-7
Subject(s) - allele , genetics , biology , population , aldolase b , nonsense mutation , genotype , missense mutation , compound heterozygosity , allele frequency , locus (genetics) , aldolase a , mutation , gene , fructose bisphosphate aldolase , medicine , enzyme , biochemistry , environmental health
Mutations in the aldolase B gene ( ALDOB ) impairing enzyme activity toward fructose‐1‐phosphate cleavage cause hereditary fructose intolerance (HFI). Diagnosis of the disease is possible by identifying known mutant ALDOB alleles in suspected patients; however, the frequencies of mutant alleles can differ by population. Here, 153 American HFI patients with 268 independent alleles were analyzed to identify the prevalence of seven known HFI‐causing alleles (A149P, A174D, N334K, Δ4E4, R59Op, A337V, and L256P) in this population. Allele‐specific oligonucleotide hybridization analysis was performed on polymerase chain reaction (PCR)‐amplified genomic DNA from these patients. In the American population, the missense mutations A149P and A174D are the two most common alleles, with frequencies of 44% and 9%, respectively. In addition, the nonsense mutations Δ4E4 and R59Op are the next most common alleles, with each having a frequency of 4%. Together, the frequencies of all seven alleles make up 65% of HFI‐causing alleles in this population. Worldwide, these same alleles make up 82% of HFI‐causing mutations. This difference indicates that screening for common HFI alleles is more difficult in the American population. Nevertheless, a genetic screen for diagnosing HFI in America can be improved by including all seven alleles studied here. Lastly, identification of HFI patients presenting with classic symptoms and who have homozygous null genotypes indicates that aldolase B is not required for proper development or metabolic maintenance.